R-Pharm US

IXEMPRA

Manufacturer:

R-Pharm US

Ixempra HCPCS:

J9207

HCPCS Code Descriptor:

Injection, ixabepilone, 1 mg

Category:

J Code

Ixempra NDCs:

70020-1911-01, 70020-1910-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

70020-1911-01, 70020-1910-01

About Ixempra:

IXEMPRA is an Oncology drug manufactured by R-Pharm US and administered via the Intravenous route of administration. The J Code: J9207 is aligned to the drug IXEMPRA.

ACCESS PRICING AND MORE BY REGISTERING

J9207 Added Date:

January 1, 2009

J9207 Effective Date:

January 1, 2009

J9207 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Ixempra billing and coding information.
Ixempra patient assistance information can be found through R-Pharm US Access and Support at the URL: https://www.ixempra.com/for-patients/get-patient-support/
IXEMPRA prescribing information can be found at the link below:
Information regarding IXEMPRA’s side effects can be found at MedlinePlus